Zealand Pharma Expects Phase 3 Dasiglucagon Results in Q2

(PLX AI) – Zealand Pharma completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI).Zealand Pharma says Dasiglucagon top-line results expected in the second quarter of 2022Pending positive results, …